References

Frontotemporal dementia

10.1016/s0140-6736(15)00461-4 · 2015 · External reference

Behavioral-variant frontotemporal dementia: distinct phenotypes with unique functional profiles

10.1212/wnl.0000000000004215 · 2017 · External reference

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

10.1093/brain/awr179 · 2011 · External reference

Effectiveness of pharmacological interventions for symptoms of behavioral variant frontotemporal dementia: a systematic review

10.1097/wnn.0000000000000217 · 2020 · External reference

Prevalence of central nervous system–active polypharmacy among older adults with dementia in the US

10.1001/jama.2021.1195 · 2021 · External reference

Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis

10.1016/j.trci.2017.10.008 · 2018 · External reference

The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries

10.1007/s00228-015-1860-9 · 2015 · External reference

Potentially harmful medication use and decline in health-related quality of life among community-dwelling older adults

10.1007/s40801-017-0123-8 · 2017 · External reference

Off-label medication use in frontotemporal dementia

10.1177/1533317509356692 · 2010 · External reference

Psychopharmacological medication use in frontotemporal dementia at the time of diagnosis: comparison with Alzheimer’s disease

10.3233/jad-230494 · 2023 · External reference

Pharmacological treatments for frontotemporal dementias: a systematic review of randomized controlled trials

10.1177/1533317513507375 · 2014 · External reference

Associated mortality risk of atypical antipsychotic medication in individuals with dementia

10.5498/wjp.v12.i2.298 · 2022 · External reference

Behavioral and cognitive response to selective serotonin reuptake inhibitors in frontotemporal lobar degeneration: a systematic review and Meta-analysis

10.1097/wnf.0000000000000469 · 2021 · External reference

Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors

10.4088/jcp.v58n0506 · 1997 · External reference

Treatment efficacy of pharmacotherapies for frontotemporal dementia: a network meta-analysis of randomized controlled trials

10.1016/j.jagp.2023.06.013 · 2023 · External reference

Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

10.1136/bmj.39335.541782.ad · 2007 · External reference

Use of hospital-based acute care among patients recently discharged from the hospital

10.1001/jama.2012.216219 · 2013 · External reference

Advances in treatment of frontotemporal dementia

10.1176/appi.neuropsych.21060166 · 2022 · External reference

Sedation-associated medications at dementia diagnosis, their receptor activity, and associations with adverse outcomes in a large clinical cohort

10.1016/j.jamda.2021.12.038 · 2022 · External reference

Safety of benzodiazepines in the geriatric population

10.1517/14740338.3.5.485 · 2004 · External reference

Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study

10.1186/s12916-020-01821-5 · 2020 · External reference

ATA practice guidelines for live, on-demand primary and urgent care

10.1089/tmj.2015.0008 · 2015 · External reference

New approaches to the treatment of frontotemporal dementia

10.1007/s13311-023-01380-6 · 2023 · External reference

Efficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia: a systematic review of randomized controlled trials

10.1177/1533317514524813 · 2014 · External reference

A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX

10.3389/fphar.2025.1516126 · 2025 · External reference

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

10.1016/s1474-4422(12)70043-1 · 2012 · External reference

TriNetX and real-world evidence: a critical review of its strengths, limitations, and bias considerations in clinical research

10.71079/aside.im.03222516 · 2025 · External reference